Mike Mitka
Abstract
A group of House and Senate Republicans sent a letter to Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, MD, questioning the FDA’s proposed regulation to allow generic drug companies to unilaterally change their drug labeling information.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A group of House and Senate Republicans sent a letter to Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, MD, questioning the FDA’s proposed regulation to allow generic drug companies to unilaterally change their drug labeling information.
Key concepts: Medicine, Food and drug administration, Drug, Drug labeling, Drug approval, Pharmacology, Family medicine